Authors relationships and activities BE reports personal fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi outside the scope of the submitted work
You should avoid this combination if you: Have liver disease or take medications processed by CYP450 enzymes Are pregnant, breastfeeding, or under 18 safety data is lacking Have a sensitive digestive system and dont tolerate GI side effects well Already take metformin or other insulin-sensitizing drugs, as stacking may be redundant or risky If any of these apply to you, consult a healthcare provider before adding berberine or consider safer, more studied alternatives
Always follow the local recommendations provided by healthcare providers or pharmacists
Compounded GLP-1 Formulations Through Telehealth Platforms Compounded medications represent a different category from FDA-approved branded medications
Week 4: Assess your progress
The electrolyte guide and fiber supplement guide address two of the most practically important nutritional supports during treatment